{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:35Z","timestamp":1794013415350,"version":"4.8.0"},"reference-count":348,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>As a complex endocrine and metabolic condition, polycystic ovarian syndrome (PCOS) affects women\u2019s reproductive health. These common symptoms include hirsutism, hyperandrogenism, ovulatory dysfunction, irregular menstruation, and infertility. No one knows what causes it or how to stop it yet. Alterations in gut microbiota composition and disruptions in secondary bile acid production appear to play a causative role in developing PCOS. PCOS pathophysiology and phenotypes are tightly related to both enteric and vaginal bacteria. Patients with PCOS exhibit changed microbiome compositions and decreased microbial diversity. Intestinal microorganisms also alter PCOS patient phenotypes by upregulating or downregulating hormone release, gut-brain mediators, and metabolite synthesis. The human body\u2019s gut microbiota, also known as the \u201csecond genome,\u201d can interact with the environment to improve metabolic and immunological function. Inflammation is connected to PCOS and may be caused by dysbiosis in the gut microbiome. This review sheds light on the recently discovered connections between gut microbiota and insulin resistance (IR) and the potential mechanisms of PCOS. This study also describes metabolomic studies to obtain a clear view of PCOS and ways to tackle it.<\/jats:p>","DOI":"10.3390\/metabo13010129","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T01:31:15Z","timestamp":1673832675000},"page":"129","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-6331","authenticated-orcid":false,"given":"Anirban Goutam","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-5606","authenticated-orcid":false,"given":"Uddesh Ramesh","family":"Wanjari","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kannampuzha","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Murali","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunraj","family":"Namachivayam","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-6217","authenticated-orcid":false,"given":"Raja","family":"Ganesan","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-0802","authenticated-orcid":false,"given":"Abhijit","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, Presidency University, Kolkata 700073, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-1938","authenticated-orcid":false,"given":"Achsha","family":"Babu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-8080","authenticated-orcid":false,"given":"Kaviyarasi","family":"Renu","sequence":"additional","affiliation":[{"name":"Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[{"name":"Stem Cell and Regenerative Medicine\/Translational Research, Department of Zoology, School of Basic Sciences, Central University of Punjab (CUPB), Bathinda 151401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-6679","authenticated-orcid":false,"given":"Gnanasambandan","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-8290","authenticated-orcid":false,"given":"George","family":"Priya Doss C.","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5167-3377","authenticated-orcid":false,"given":"Nehal","family":"Elsherbiny","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia"},{"name":"Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Elsherbini","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Faculty of Dentistry, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7765-5035","authenticated-orcid":false,"given":"Alsamman M.","family":"Alsamman","sequence":"additional","affiliation":[{"name":"Department of Genome Mapping, Molecular Genetics and Genome Mapping Laboratory, Agricultural Genetic Engineering Research Institute, Giza 12619, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-6638","authenticated-orcid":false,"given":"Hatem","family":"Zayed","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-0492","authenticated-orcid":false,"given":"Abilash Valsala","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tabassum, F., Jyoti, C., Sinha, H.H., Dhar, K., and Akhtar, M.S. (2021). Impact of polycystic ovary syndrome on quality of life of women in correlation to age, basal metabolic index, education and marriage. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247486"},{"key":"ref_4","first-page":"9","article-title":"Polycystic ovary syndrome and its impact on women\u2019s quality of life: More than just an endocrine disorder","volume":"1","author":"Brady","year":"2009","journal-title":"Drug Healthc. Patient Saf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","article-title":"Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review","volume":"13","author":"He","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wolf, W.M., Wattick, R.A., Kinkade, O.N., and Olfert, M.D. (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15112589"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rao, M., Broughton, K.S., and LeMieux, M.J. (2020). Cross-sectional Study on the Knowledge and Prevalence of PCOS at a Multiethnic University. Prog. Prev. Med., e0028.","DOI":"10.1097\/pp9.0000000000000028"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kyrou, I., Karteris, E., Robbins, T., Chatha, K., Drenos, F., and Randeva, H.S. (2020). Polycystic ovary syndrome (PCOS) and COVID-19: An overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med., 18.","DOI":"10.1186\/s12916-020-01697-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/humrep\/dex226","article-title":"Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: Redefining threshold levels for follicle count and serum anti-M\u00fcllerian hormone using cluster analysis","volume":"32","author":"Laven","year":"2017","journal-title":"Hum. Reprod."},{"key":"ref_11","first-page":"2633494120913032","article-title":"Controversies in the diagnosis of polycystic ovary syndrome","volume":"14","author":"Rao","year":"2020","journal-title":"Ther. Adv. Reprod. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40738-017-0035-z","article-title":"Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: A cross sectional study","volume":"3","author":"Reid","year":"2017","journal-title":"Fertil. Res. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Teede, H., Deeks, A., and Moran, L. (2010). Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-41"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kelsey, T.W., Dodwell, S.K., Wilkinson, A.G., Greve, T., Andersen, C.Y., Anderson, R.A., and Wallace, W.H. (2013). Ovarian volume throughout life: A validated normative model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071465"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-rotterdam: A common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome","volume":"91","author":"Murphy","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000481532","article-title":"New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile","volume":"88","author":"Merino","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","article-title":"Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries","volume":"98","author":"Rosenfield","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijem.IJEM_30_19","article-title":"Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene","volume":"23","author":"Sachdeva","year":"2019","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Polak, A.M., Adamska, A., Krentowska, A., \u0141ebkowska, A., Hryniewicka, J., Adamski, M., and Kowalska, I. (2020). Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030732"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","article-title":"Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process","volume":"33","author":"Mimouni","year":"2021","journal-title":"Cell Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"bnaa010","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome","volume":"41","author":"Padmanabhan","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S2040174417001118","article-title":"Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure","volume":"9","author":"Barrett","year":"2018","journal-title":"J. Dev. Orig. Health Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/eva.13244","article-title":"Endometriosis and polycystic ovary syndrome are diametric disorders","volume":"14","author":"Dinsdale","year":"2021","journal-title":"Evol. Appl."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","article-title":"The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility","volume":"37","author":"Bedenk","year":"2020","journal-title":"J. Assist. Reprod Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Kunicki, M., Calik-Ksepka, A., Suchta, K., Duszewska, A., Smolarczyk, K., and Smolarczyk, R. (2021). Anti-M\u00fcllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. Int J. Mol. Sci, 22.","DOI":"10.3390\/ijms222212507"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"938138","DOI":"10.1100\/2012\/938138","article-title":"Biology and Biotechnology of Follicle Development","volume":"2012","author":"Palma","year":"2012","journal-title":"Sci. World J."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Almeida, F., Costermans, N.G.J., Soede, N.M., Bunschoten, A., Keijer, J., Kemp, B., and Teerds, K.J. (2018). Presence of anti-M\u00fcllerian hormone (AMH) during follicular development in the porcine ovary. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197894"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105439","DOI":"10.1016\/j.jsbmb.2019.105439","article-title":"Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review","volume":"194","author":"Schiffer","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"111239","DOI":"10.1016\/j.mce.2021.111239","article-title":"Adrenal androgens, adrenarche, and zona reticularis: A human affair?","volume":"528","author":"Dumontet","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"bvac037","DOI":"10.1210\/jendso\/bvac037","article-title":"11-Oxyandrogens in Adolescents with Polycystic Ovary Syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome","volume":"102","author":"Kempegowda","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1179558119874042","DOI":"10.1177\/1179558119874042","article-title":"Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies","volume":"13","author":"Barber","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4755-12-7","article-title":"A case\u2013control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria","volume":"12","author":"Jamil","year":"2015","journal-title":"Reprod. Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","article-title":"Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review","volume":"13","author":"Livadas","year":"2022","journal-title":"World J. Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2147454","DOI":"10.1001\/jamanetworkopen.2021.47454","article-title":"Prevalence of Polycystic Ovary Syndrome in Patients with Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis","volume":"5","author":"Cioana","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12020-020-02596-8","article-title":"Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome","volume":"72","author":"Krentowska","year":"2021","journal-title":"Endocrine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-20-1163","article-title":"Increased COVID-19 infections in women with polycystic ovary syndrome: A population-based study","volume":"184","author":"Subramanian","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11154-022-09715-y","article-title":"Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review","volume":"23","author":"Yamamoto","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The Human Gut Microbiome\u2014A Potential Controller of Wellness and Disease","volume":"9","author":"Kho","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3389\/fimmu.2020.02184","article-title":"Female Gut and Genital Tract Microbiota-Induced Crosstalk and Differential Effects of Short-Chain Fatty Acids on Immune Sequelae","volume":"11","author":"Amabebe","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3389\/fimmu.2018.01830","article-title":"Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer","volume":"9","author":"Lazar","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): A Review","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Giampaolino, P., Foreste, V., Di Filippo, C., Gallo, A., Mercorio, A., Serafino, P., Improda, F.P., Verrazzo, P., Zara, G., and Buonfantino, C. (2021). Microbiome and PCOS: State-of-Art and Future Aspects. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042048"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"808508","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and Vaginal Microbiomes in PCOS: Implications for Women\u2019s Health","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tem.2021.04.014","article-title":"Gut and vaginal microbiomes on steroids: Implications for women\u2019s health","volume":"32","author":"Graham","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, Microbes, and Polycystic Ovary Syndrome","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_60","first-page":"143","article-title":"Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer","volume":"4","author":"Chetta","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2016.02.010","article-title":"Steroidogenic pathways involved in androgen biosynthesis in eumenorrheic women and patients with polycystic ovary syndrome","volume":"158","author":"Saito","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Crommen, S., and Simon, M.C. (2017). Microbial Regulation of Glucose Metabolism and Insulin Resistance. Genes, 9.","DOI":"10.3390\/genes9010010"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiol.00041.2015","article-title":"Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance","volume":"31","author":"Saad","year":"2016","journal-title":"Physiology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med. Hypotheses"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/pr3000317","article-title":"Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients","volume":"11","author":"Sun","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/EJE-14-0589","article-title":"Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation","volume":"172","author":"Zhang","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","article-title":"A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota","volume":"39","author":"Yurtdas","year":"2020","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/gutjnl-2015-311326","article-title":"The effect of heritability and host genetics on the gut microbiota and metabolic syndrome","volume":"66","author":"Lim","year":"2017","journal-title":"Gut"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lindheim, L., Bashir, M., Munzker, J., Trummer, C., Zachhuber, V., Leber, B., Horvath, A., Pieber, T.R., Gorkiewicz, G., and Stadlbauer, V. (2017). Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168390"},{"key":"ref_73","first-page":"324","article-title":"Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut Microbial Diversity in Women with Polycystic Ovary Syndrome Correlates with Hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrgastro.2016.4","article-title":"Gut microbiota in 2015: Prevotella in the gut: Choose carefully","volume":"13","author":"Ley","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","article-title":"Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): A pilot study","volume":"170","author":"Zeng","year":"2019","journal-title":"Res. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","article-title":"Multi-system reproductive metabolic disorder: Significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)","volume":"228","author":"Li","year":"2019","journal-title":"Life Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1159\/000430229","article-title":"Nutritional aspects of depression","volume":"37","author":"Lang","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/humrep\/dev231","article-title":"Gastrointestinal hormone secretion in women with polycystic ovary syndrome: An observational study","volume":"30","author":"Lin","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Haro, C., Rangel-Zuniga, O.A., Alcala-Diaz, J.F., Gomez-Delgado, F., Perez-Martinez, P., Delgado-Lista, J., Quintana-Navarro, G.M., Landa, B.B., Navas-Cortes, J.A., and Tena-Sempere, M. (2016). Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154090"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., and Tang, L. (2016). Association between Polycystic Ovary Syndrome and Gut Microbiota. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153196"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/s41598-017-02995-4","article-title":"Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Dominianni, C., Sinha, R., Goedert, J.J., Pei, Z., Yang, L., Hayes, R.B., and Ahn, J. (2015). Sex, body mass index, and dietary fiber intake influence the human gut microbiome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124599"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"23001","DOI":"10.1038\/srep23001","article-title":"Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice","volume":"6","author":"Harada","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0954422418000136","article-title":"Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome","volume":"31","author":"Barrea","year":"2018","journal-title":"Nutr. Res. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4014\/jmb.1710.10001","article-title":"Difference in the Gut Microbiome between Ovariectomy-Induced Obesity and Diet-Induced Obesity","volume":"27","author":"Choi","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-021-00799-9","article-title":"The gut microbial composition in polycystic ovary syndrome with insulin resistance: Findings from a normal-weight population","volume":"14","author":"He","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/JOE-19-0589","article-title":"The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome","volume":"245","author":"Qi","year":"2020","journal-title":"J. Endocrinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41574-019-0255-x","article-title":"IL-22 links gut microbiota to PCOS","volume":"15","author":"Kriebs","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"110958","DOI":"10.1016\/j.biopha.2020.110958","article-title":"Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e00017-19","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2011-2607","article-title":"Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women","volume":"97","author":"Kluge","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal. Transduct Target."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20945\/2359-3997000000197","article-title":"Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin","volume":"64","author":"Cardoso","year":"2020","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical Practice. Polycystic Ovary Syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"110609","DOI":"10.1016\/j.nut.2019.110609","article-title":"Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases","volume":"71","year":"2020","journal-title":"Nutrition"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Rajska, A., Buszewska-Forajta, M., Rachon, D., and Markuszewski, M.J. (2020). Metabolomic Insight into Polycystic Ovary Syndrome-An Overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144853"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Alhilali, M.J., Parham, A., Attaranzadeh, A., Amirian, M., and Azizzadeh, M. (2020). Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome. BMC Pregnancy Childbirth, 20.","DOI":"10.1186\/s12884-020-03379-9"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","article-title":"Metabolic disturbances in non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"111","author":"Zhu","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Kelley, S.T., Skarra, D.V., Rivera, A.J., and Thackray, V.G. (2016). The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146509"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2020.01.027","article-title":"Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome","volume":"113","author":"Chu","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41522-021-00231-6","article-title":"Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients","volume":"7","author":"Chen","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1111\/eci.13417","article-title":"Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population","volume":"51","author":"Mammadova","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fphys.2020.01108","article-title":"Comparative Analysis of Lower Genital Tract Microbiome Between PCOS and Healthy Women","volume":"11","author":"Tu","year":"2020","journal-title":"Front. Physiol"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"103696","DOI":"10.1016\/j.micpath.2019.103696","article-title":"Crosstalk between Vaginal Microbiome and Female Health: A review","volume":"136","author":"Gupta","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1471-0528.15972","article-title":"The association between vaginal bacterial composition and miscarriage: A nested case-control study","volume":"127","author":"Bobdiwala","year":"2020","journal-title":"BJOG"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2019.03.011","article-title":"The influence of the vaginal microbiota on preterm birth: A systematic review and recommendations for a minimum dataset for future research","volume":"79","author":"Peelen","year":"2019","journal-title":"Placenta"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.12.035","article-title":"Bacterial vaginosis-A brief synopsis of the literature","volume":"245","author":"Coudray","year":"2020","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/humrep\/dez065","article-title":"The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: A prospective study","volume":"34","author":"Koedooder","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/cen.14198","article-title":"Association between polycystic ovary syndrome and the vaginal microbiome: A case-control study","volume":"93","author":"Hong","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","article-title":"Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients","volume":"9","author":"Sarenac","year":"2018","journal-title":"Front. Pharm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1631\/jzus.B1900073","article-title":"Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases","volume":"20","author":"Jia","year":"2019","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jsbmb.2019.03.005","article-title":"Increased circulating conjugated primary bile acids are associated with hyperandrogenism in women with polycystic ovary syndrome","volume":"189","author":"Zhang","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., and Li, X. (2020). Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176356"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10096-017-3143-0","article-title":"Gut microbiome production of short-chain fatty acids and obesity in children","volume":"37","author":"Murugesan","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mam.2016.09.003","article-title":"The microbial epigenome in metabolic syndrome","volume":"54","author":"Remely","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1360\/N972018-00587","article-title":"Probiotic Bifidobacterium lactis V9 regulates the intestinal microbiome in patients with polycystic ovary syndrome","volume":"64","author":"Ma","year":"2019","journal-title":"Chin. Sci. Bull."},{"key":"ref_129","first-page":"810","article-title":"Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?","volume":"102","author":"Li","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","article-title":"Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.18632\/oncotarget.23393","article-title":"Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome","volume":"9","author":"Jove","year":"2018","journal-title":"Oncotarget"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41467-020-16274-w","article-title":"Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels","volume":"11","author":"Johnson","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11306-019-1596-0","article-title":"Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism","volume":"15","author":"Kayser","year":"2019","journal-title":"Metabolomics"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: A systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e2122844","DOI":"10.1001\/jamanetworkopen.2021.22844","article-title":"Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study","volume":"4","author":"Lemaitre","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3945\/ajcn.117.157107","article-title":"Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes","volume":"106","author":"Shan","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: The POUNDS Lost trial","volume":"68","author":"Heianza","year":"2019","journal-title":"Gut"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cmet.2019.08.021","article-title":"Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction","volume":"30","author":"Chen","year":"2019","journal-title":"Cell Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/cen.14101","article-title":"Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome","volume":"91","author":"Eyupoglu","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"112171","DOI":"10.1016\/j.biopha.2021.112171","article-title":"Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory","volume":"143","author":"Annunziata","year":"2021","journal-title":"Biomed. Pharm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6306410","DOI":"10.1155\/2016\/6306410","article-title":"Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols","volume":"2016","author":"Lagana","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): An update","volume":"303","year":"2021","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7861\/clinmedicine.16-3-262","article-title":"Polycystic ovary syndrome: Insight into pathogenesis and a common association with insulin resistance","volume":"16","author":"Barber","year":"2016","journal-title":"Clin. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"101189","DOI":"10.1016\/j.molmet.2021.101189","article-title":"Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production","volume":"49","author":"Yang","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Lerner, A., Kewada, D., Ahmed, A., Hardy, K., Christian, M., and Franks, S. (2020). Androgen Reduces Mitochondrial Respiration in Mouse Brown Adipocytes: A Model for Disordered Energy Balance in Polycystic Ovary Syndrome. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010243"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.18632\/aging.202938","article-title":"Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Kany, S., Vollrath, J.T., and Relja, B. (2019). Cytokines in Inflammatory Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236008"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cyto.2016.12.020","article-title":"Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization","volume":"91","author":"Niu","year":"2017","journal-title":"Cytokine"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"103345","DOI":"10.1016\/j.jri.2021.103345","article-title":"Increased pro-inflammatory cytokines in ovary and effect of gamma-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model","volume":"146","author":"Prabhu","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Regidor, P.A., Mueller, A., Sailer, M., Gonzalez Santos, F., Rizo, J.M., and Egea, F.M. (2020). Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010384"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2012.03.056","article-title":"Adipose expression of adipocytokines in women with polycystic ovary syndrome","volume":"98","author":"Svendsen","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/ijo.2016.154","article-title":"Proinflammatory environment and role of TNF-alpha in endometrial function of obese women having polycystic ovarian syndrome","volume":"40","author":"Orostica","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Altonen, B.L., Arreglado, T.M., Leroux, O., Murray-Ramcharan, M., and Engdahl, R. (2020). Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243343"},{"key":"ref_156","first-page":"165","article-title":"Evaluation of TNF-alpha and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol","volume":"21","author":"Ghowsi","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1210\/jc.2015-4275","article-title":"Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women with Polycystic Ovarian Syndrome","volume":"101","author":"Adams","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09513590.2017.1371691","article-title":"Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)","volume":"34","author":"Artimani","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"103083","DOI":"10.1016\/j.jri.2020.103083","article-title":"IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization","volume":"138","author":"Zhang","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13813455.2018.1499120","article-title":"Insulin resistance and oxidative marker in women with PCOS","volume":"126","author":"Bannigida","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biopsych.2017.05.027","article-title":"Maternal Systemic Interleukin-6 During Pregnancy Is Associated with Newborn Amygdala Phenotypes and Subsequent Behavior at 2 Years of Age","volume":"83","author":"Graham","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Peng, Z., Sun, Y., Lv, X., Zhang, H., Liu, C., and Dai, S. (2016). Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157389"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.fertnstert.2019.07.606","article-title":"The effect of interleukin 6 on controlled ovarian stimulation results and IVF outcome in infertile women with adenomyosis undergoing IVF","volume":"112","author":"Kim","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/bjc.2015.154","article-title":"Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis","volume":"112","author":"Srivastava","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/a-1018-9606","article-title":"Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial","volume":"51","author":"Ali","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/jc.2002-021437","article-title":"Association of low interleukin-10 levels with the metabolic syndrome in obese women","volume":"88","author":"Esposito","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.mgene.2016.08.001","article-title":"Interleukin 10 (-1082 G\/A) and (-819 C\/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS)","volume":"9","author":"Talaat","year":"2016","journal-title":"Meta Gene"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2018.06.007","article-title":"Clomiphene citrate increases nitric oxide, interleukin-10 and reduces matrix metalloproteinase-9 in women with polycystic ovary syndrome","volume":"228","author":"Sylus","year":"2018","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1933719116653681","article-title":"Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients with Polycystic Ovary Syndrome","volume":"24","author":"Long","year":"2017","journal-title":"Reprod. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/09513590.2017.1395835","article-title":"The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome","volume":"34","author":"Dawood","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"758656","DOI":"10.1155\/2010\/758656","article-title":"Mediators of inflammation in polycystic ovary syndrome in relation to adiposity","volume":"2010","author":"Sathyapalan","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e021860","DOI":"10.1136\/bmjopen-2018-021860","article-title":"Assessing C reactive protein\/albumin ratio as a new biomarker for polycystic ovary syndrome: A case-control study of women from Bahraini medical clinics","volume":"8","author":"Kalyan","year":"2018","journal-title":"BMJ Open"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci","year":"2017","journal-title":"Gynecol.Endocrinol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_176","first-page":"19","article-title":"C-Reactive Protein and Adiposity in Women with Polycystic Ovary Syndrome","volume":"23","author":"Fathi","year":"2018","journal-title":"Tikrit J. Pure Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.14260\/jemds\/2016\/1305","article-title":"CRP levels and endothelial function in young women with PCOS","volume":"5","author":"Neelaveni","year":"2016","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","article-title":"Is PCOS an inflammatory process?","volume":"97","author":"Duleba","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09513590600630447","article-title":"Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?","volume":"22","author":"Meydanli","year":"2006","journal-title":"Gynecol. Endocrinol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/09513590.2010.501874","article-title":"Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome","volume":"27","author":"Cakal","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diabetes.52.4.942","article-title":"Association between adiponectin and mediators of inflammation in obese women","volume":"52","author":"Engeli","year":"2003","journal-title":"Diabetes"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2017.05.014","article-title":"The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women","volume":"214","author":"Tola","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. Endocrinol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09513590.2014.976546","article-title":"The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Soares","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4092470","DOI":"10.1155\/2020\/4092470","article-title":"Inflammatory markers in women with polycystic ovary syndrome","volume":"2020","author":"Rudnicka","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1113\/JP271694","article-title":"The vaginal microbiota, host defence and reproductive physiology","volume":"595","author":"Smith","year":"2017","journal-title":"J. Physiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI129194","article-title":"The gut microbiome and metabolic syndrome","volume":"129","author":"Dabke","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ajog.2018.11.1089","article-title":"Gynecology. Ecological dynamics of the vaginal microbiome in relation to health and disease","volume":"220","author":"Greenbaum","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"755741","DOI":"10.3389\/fcimb.2021.755741","article-title":"Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e13220","DOI":"10.1111\/aji.13220","article-title":"Fertility factors affect the vaginal microbiome in women of reproductive age","volume":"83","author":"Xu","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_193","first-page":"3","article-title":"\u201cOmics\u201d in pharmaceutical research: Overview, applications, challenges, and future perspectives","volume":"13","author":"Yan","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/molehr\/gam036","article-title":"Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome","volume":"13","author":"Ma","year":"2007","journal-title":"MHR Basic Sci. Reprod. Med."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Jungert, A., and Frank, J. (2021). Intra-Individual Variation and Reliability of Biomarkers of the Antioxidant Defense System by Considering Dietary and Lifestyle Factors in Premenopausal Women. Antioxidants, 10.","DOI":"10.3390\/antiox10030448"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/jcp.24002","article-title":"Challenges and opportunities of metabolomics","volume":"227","author":"Johnson","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"Metabolism. The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.1.02058","article-title":"Metabolic syndrome in polycystic ovary syndrome (PCOS): Lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS","volume":"154","author":"Carmina","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1042\/bj0331122","article-title":"The electrophoretic analysis of normal human serum","volume":"33","author":"Kekwick","year":"1939","journal-title":"Biochem. J."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Psychogios, N., Hau, D.D., Peng, J., Guo, A.C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., and Gautam, B. (2011). The human serum metabolome. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016957"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.jproteome.9b00574","article-title":"Serum metabolomics reveals personalized metabolic patterns for macular neovascular disease patient stratification","volume":"19","author":"Liu","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_204","unstructured":"Jin-Wei, H., Sa, Y.-H., Song, J., and Sun, Z. (2022). Pseudo-targeted metabolomic analysis of Chinese Herbal Medicines Cangfu Daotan Decoction to improve in vitro fertilization outcomes of patients with Polycystic Ovary Syndrome. Res. Sq., preprint."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/0471142727.mb3002s98","article-title":"Targeted metabolomics","volume":"98","author":"Roberts","year":"2012","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"O\u017cegowska, K., Plewa, S., Mantaj, U., Pawelczyk, L., and Matysiak, J. (2021). Serum Metabolomics in PCOS Women with Different Body Mass Index. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132811"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jsbmb.2018.10.012","article-title":"Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique","volume":"186","author":"Stefaniak","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Yu, Y., Tan, P., Zhuang, Z., Wang, Z., Zhu, L., Qiu, R., and Xu, H. (2021). Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome. BMC Med. Genom., 14.","DOI":"10.1186\/s12920-021-01058-y"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","article-title":"Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients","volume":"185","author":"Liu","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1542\/peds.2015-1430","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"136","author":"Rosenfield","year":"2015","journal-title":"Pediatrics"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_214","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: Relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1979654","DOI":"10.1155\/2016\/1979654","article-title":"Inositol treatment and ART outcomes in women with PCOS","volume":"2016","author":"Garg","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1111\/jcmm.15541","article-title":"The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"50","author":"Essah","year":"2007","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"ref_220","first-page":"191","article-title":"Study of levels of malondialdehyde, super oxide dismutase and hs-CRP in serum of non-obese patients with polycystic ovarian syndrome","volume":"4","author":"Deba","year":"2017","journal-title":"Int. J. Clin. Biochem."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fendo.2019.00873","article-title":"The association between serum ferritin concentration and visceral adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome","volume":"10","author":"Adamska","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum. Reprod."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2010.539251","article-title":"Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)","volume":"46","author":"Hossain","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-16-1063","article-title":"Management of endocrine disease: Polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications","volume":"33","author":"Dunaif","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: An update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"key":"ref_233","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Lemieux","year":"2006","journal-title":"Nature"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/cen.12258","article-title":"A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease","volume":"80","author":"Dawson","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Kinkhabwala","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"e000352","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/etm.2017.4642","article-title":"Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy","volume":"14","author":"Yao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manneras","year":"2007","journal-title":"Endocrinology"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"611","DOI":"10.5812\/ijem.4020","article-title":"Cardiovascular risk in women with PCOS","volume":"10","author":"Scicchitano","year":"2012","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_242","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"33715","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): A meta-analysis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: Insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: Systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Papavassiliou","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: A northern Finland birth cohort 1966 study","volume":"104","author":"Ollila","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: Consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"18","author":"Meyer","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"ref_250","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Teede","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","article-title":"Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: A meta-analysis","volume":"14","author":"Yang","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.dsx.2018.03.014","article-title":"Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis","volume":"12","author":"Fazleen","year":"2018","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Hung, J.-H., Hu, L.-Y., Tsai, S.-J., Yang, A.C., Huang, M.-W., Chen, P.-M., Wang, S.-L., Lu, T., and Shen, C.-C. (2014). Risk of psychiatric disorders following polycystic ovary syndrome: A nationwide population-based cohort study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097041"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum. Reprod."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40519-018-0533-y","article-title":"Increased odds of disordered eating in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"24","author":"Lee","year":"2019","journal-title":"Eat. Weight Disord. Stud. Anorex. Bulim. Obes. Rev."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2019.06.018","article-title":"Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety","volume":"112","author":"Chemerinski","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09513590600604541","article-title":"Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)","volume":"22","author":"Coffey","year":"2006","journal-title":"Gynecol. Endocrinol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgz256","article-title":"Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms","volume":"105","author":"Karjula","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_261","first-page":"27","article-title":"Oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome","volume":"1","author":"Ergen","year":"2012","journal-title":"Med. Sci."},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A.M., Smolarczyk, R., and Meczekalski, B. (2021). Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073789"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(90)80565-Z","article-title":"Granulosa cells as a source and target organ for tumor necrosis factor-\u03b1","volume":"261","author":"Zolti","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0015-0282(16)55438-7","article-title":"Tumor necrosis factor \u03b1 in the human ovary: Presence in follicular fluid and effects on cell proliferation and prostaglandin production","volume":"58","author":"Wang","year":"1992","journal-title":"Fertil. Steril."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1210\/endo-129-2-641","article-title":"Ovarian actions of tumor necrosis factor-\u03b1 (TNF\u03b1): Pleiotropic effects of TNF\u03b1 on differentiated functions of untransformed swine granulosa cells","volume":"129","author":"Veldhuis","year":"1991","journal-title":"Endocrinology"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/endo-126-5-2711","article-title":"Effects of tumor necrosis factor-\u03b1 in vitro on steroidogenesis of healthy and atretic follicles of the rat: Theca as a target","volume":"126","author":"Roby","year":"1990","journal-title":"Endocrinology"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1071\/RD9950067","article-title":"Effects of tumour necrosis factor alpha (TNF alpha) on ovulation in the rat ovary","volume":"7","author":"Brannstrom","year":"1995","journal-title":"Reprod. Fertil. Dev."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1016\/S0021-9258(18)54714-1","article-title":"Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha","volume":"266","author":"Stephens","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/edrv-11-3-454","article-title":"The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series","volume":"11","author":"Adashi","year":"1990","journal-title":"Endocr. Rev."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"247","DOI":"10.20452\/pamw.144","article-title":"Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease","volume":"117","author":"Mroczko","year":"2007","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","article-title":"Interleukin-8 and human cancer biology","volume":"12","author":"Xie","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/endo.137.9.8756544","article-title":"Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells","volume":"137","author":"Arici","year":"1996","journal-title":"Endocrinology"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum. Reprod. Update"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9378(98)70474-0","article-title":"Evidence for a neutrophil\u2013interleukin-8 system in human folliculogenesis","volume":"178","author":"Chang","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/13.10.2738","article-title":"Peripheral blood mononuclear cells stimulate progesterone production by luteal cells derived from pregnant and non-pregnant women: Possible involvement of interleukin-4 and interleukin-10 in corpus luteum function and differentiation","volume":"13","author":"Hashii","year":"1998","journal-title":"Hum. Reprod."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/db06-0047","article-title":"Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects","volume":"55","author":"Scarpelli","year":"2006","journal-title":"Diabetes"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2010.02.010","article-title":"Tumor necrosis factor \u03b1 (\u2212308), interleukin-6 (\u2212174) and interleukin-10 (\u22121082) gene polymorphisms in polycystic ovary syndrome","volume":"150","author":"Vural","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. Endocrinol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biocel.2011.03.001","article-title":"Cytokines: Signalling molecules controlling ovarian functions","volume":"43","author":"Sirotkin","year":"2011","journal-title":"Int. J. Biochem. Cell Biol. Int."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2796.2003.01177.x","article-title":"Metabolic disturbances in obesity versus sleep apnoea: The importance of visceral obesity and insulin resistance","volume":"254","author":"Vgontzas","year":"2003","journal-title":"J. Intern. Med."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction","volume":"77","year":"2012","journal-title":"Steroids"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","article-title":"Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: Relationship of carotid intima-media wall thickness and cardiovascular risk factors","volume":"93","author":"Kaya","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: Relationship to insulin resistance and to obesity","volume":"89","author":"Villuendas","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"375","DOI":"10.29252\/ijrm.15.6.375","article-title":"Polycystic ovary syndrome and circulating inflammatory markers","volume":"15","author":"Zangeneh","year":"2017","journal-title":"Int. J. Reprod. BioMed."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4239\/wjd.v5.i2.89","article-title":"New insights into insulin: The anti-inflammatory effect and its clinical relevance","volume":"5","author":"Sun","year":"2014","journal-title":"World J. Diabetes"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2567.2010.03281.x","article-title":"The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1)","volume":"131","author":"Woodward","year":"2010","journal-title":"Immunology"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ni.2406","article-title":"From IL-2 to IL-37: The expanding spectrum of anti-inflammatory cytokines","volume":"13","author":"Banchereau","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_296","first-page":"155187","article-title":"The hallmark of pro-and anti-inflammatory cytokine ratios in women with polycystic ovary syndrome","volume":"134","author":"Tosatti","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.2012.04454.x","article-title":"Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance","volume":"78","author":"Phelan","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-018-0519-z","article-title":"Androgen therapy for acute myeloid and hairy cell leukemia","volume":"19","author":"Wiernik","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biochi.2014.10.028","article-title":"Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise","volume":"124","author":"Covington","year":"2016","journal-title":"Biochimie"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E.-D., and Amer, S. (2021). The role of chronic inflammation in polycystic ovarian syndrome\u2014A systematic review and meta-analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052734"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"001","DOI":"10.1159\/000083634","article-title":"Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance","volume":"15","author":"Barvitenko","year":"2005","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmed.2018.00217","article-title":"The role of neutrophils and neutrophil elastase in pulmonary arterial hypertension","volume":"5","author":"Taylor","year":"2018","journal-title":"Front. Med."},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Almaeen, A.H., Alduraywish, A.A., Nabi, M., Shah, N.N., Shaik, R., and Tantry, B.A. (2022). Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome. Medicina, 58.","DOI":"10.3390\/medicina58040535"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","article-title":"The inflammatory markers in polycystic ovary syndrome: Association with obesity and IVF outcomes","volume":"39","author":"Vural","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40618-015-0335-2","article-title":"The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome","volume":"39","author":"Yilmaz","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_306","first-page":"91","article-title":"White blood cells levels and PCOS: Direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia","volume":"14","author":"Papalou","year":"2015","journal-title":"Hormones"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00394-019-02033-1","article-title":"The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"59","author":"Shamasbi","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1007\/s00394-020-02233-0","article-title":"Therapy with probiotics and synbiotics for polycystic ovarian syndrome: A systematic review and meta-analysis","volume":"59","author":"Cozzolino","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_309","doi-asserted-by":"crossref","unstructured":"Xu, L.-H., and Zhang, F. (2022). Meta-analysis of the endocrine and metabolic effects of probiotics on polycystic ovary syndrome. Res. Sq., preprint.","DOI":"10.21203\/rs.3.rs-933982\/v1"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/14647273.2017.1283446","article-title":"Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial","volume":"20","author":"Ahmadi","year":"2017","journal-title":"Hum. Fertil."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2008-7802.153866","article-title":"Effects of probiotic supplementation on pancreatic \u03b2-cell function and c-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial","volume":"6","author":"Shoaei","year":"2015","journal-title":"Int. J. Prev. Med."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jff.2017.06.029","article-title":"Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome","volume":"36","author":"Rashad","year":"2017","journal-title":"J. Funct. Foods"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-018-0457-1","article-title":"The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome","volume":"11","author":"Jamilian","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jff.2017.12.047","article-title":"The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial","volume":"42","author":"Ghanei","year":"2018","journal-title":"J. Funct. Foods"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/gutjnl-2020-320992","article-title":"Improvement in sperm quality and spermatogenesis following faecal microbiota transplantation from alginate oligosaccharide dosed mice","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3389\/fimmu.2019.02653","article-title":"Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases","volume":"10","author":"Quaranta","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jnutbio.2012.05.008","article-title":"Positive and negative regulation of insulin action by genistein in the endothelium","volume":"24","author":"Gao","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/mnfr.201200284","article-title":"Genistein and daidzein, typical soy isoflavones, inhibit TNF-\u03b1-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes","volume":"56","author":"Yanagisawa","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_319","first-page":"297","article-title":"Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome","volume":"16","author":"Khani","year":"2011","journal-title":"J. Res. Med. Sci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1210\/jc.2016-1762","article-title":"The effects of soy isoflavones on metabolic status of patients with polycystic ovary syndrome","volume":"101","author":"Jamilian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18502\/ijrm.v17i1.3816","article-title":"Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome","volume":"17","author":"Rajaei","year":"2019","journal-title":"Int. J. Reprod. BioMed."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1080\/09513590.2019.1624715","article-title":"Therapeutic effects of isoflavone-aglycone fraction from soybean (Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state","volume":"35","author":"Khazali","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Zhang, T., and Chi, X. (2019). Estrogenic properties of genistein acting on FSHR and LHR in rats with PCOS. Pol. J. Vet. Sci.","DOI":"10.24425\/pjvs.2019.127075"},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Haudum, C., Lindheim, L., Ascani, A., Trummer, C., Horvath, A., M\u00fcnzker, J., and Obermayer-Pietsch, B. (2020). Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics. Nutrients, 12.","DOI":"10.3390\/nu12061622"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.abb.2014.06.007","article-title":"Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake","volume":"559","author":"Franke","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2014.09.003","article-title":"Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats","volume":"49","author":"Patisaul","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.fertnstert.2007.09.020","article-title":"Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study","volume":"90","author":"Romualdi","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"072","DOI":"10.7324\/JAPS.2020.102012","article-title":"Effect of ethanolic seed extract of Caesalpinia bonducella on hormones in mifepristone induced PCOS rats","volume":"10","author":"Balasubramanian","year":"2020","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/jbcpp.2011.006","article-title":"Effect of graded doses of Caesalpinia bonducella seed extract on ovary and uterus in albino rats","volume":"22","author":"Salunke","year":"2011","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"114375","DOI":"10.1016\/j.jep.2021.114375","article-title":"Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS): A review","volume":"279","author":"Kandasamy","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1021\/np50047a025","article-title":"Caesalpin F: A New Furanoditerpene from Caesalpinia bonducella","volume":"49","author":"Pascoe","year":"1986","journal-title":"J. Nat. Prod."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"274","DOI":"10.51248\/.v39i2.195","article-title":"Effect of ethanolic seed extract of Caesalpinia bonducella on Mifepristone induced PCOS rats","volume":"39","author":"Balasubramanian","year":"2022","journal-title":"Biomedicine"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/humupd\/dmu037","article-title":"Metformin in reproductive health, pregnancy and gynaecological cancer: Established and emerging indications","volume":"20","author":"Sivalingam","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1530\/EC-19-0449","article-title":"Long-term efficacy of metformin in overweight-obese PCOS: Longitudinal follow-up of retrospective cohort","volume":"9","author":"Jensterle","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_335","first-page":"785","article-title":"Metformin for the treatment of polycystic ovary syndrome","volume":"101","author":"Barbieri","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"ref_336","first-page":"577","article-title":"Use of Metformin in the Treatment of Polycystic Ovary Syndrome","volume":"6","author":"Genazzani","year":"2010","journal-title":"Women\u2019s Health"},{"key":"ref_337","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"ref_339","unstructured":"Pal, L., and Seifer, D.B. (2022). Newer Glucose-Lowering Medications and Potential Role in Metabolic Management of PCOS. Polycystic Ovary Syndrome: Current and Emerging Concepts, Springer International Publishing."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1210\/jc.2012-2396","article-title":"Mechanism of action of DPP-4 inhibitors\u2014New insights","volume":"97","author":"Vella","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.beem.2009.03.004","article-title":"Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)","volume":"23","author":"Thornberry","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_342","first-page":"S8","article-title":"The physiologic role of incretin hormones: Clinical applications","volume":"110","author":"Cefalu","year":"2010","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1039\/C9FO02554E","article-title":"Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota","volume":"11","author":"He","year":"2020","journal-title":"Food Funct."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00394-018-1648-7","article-title":"The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: A randomized, triple-blind, controlled, clinical trial","volume":"58","author":"Dehgan","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1210\/jc.2012-1205","article-title":"Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes","volume":"97","author":"Muscelli","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.fertnstert.2010.06.058","article-title":"Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: A prospective randomized study","volume":"95","author":"Naka","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5603\/EP.a2022.0047","article-title":"Therapy of obesity in women with PCOS using GLP-1 analogues\u2014Benefits and limitations [Terapia oty\u0142o\u015bci u kobiet z PCOS przy zastosowaniu analog\u00f3w GLP-1\u2014Korzy\u015bci i ograniczenia]","volume":"73","year":"2022","journal-title":"Endokrynol. Pol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/129\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:05Z","timestamp":1760119565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/1\/129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":348,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["metabo13010129"],"URL":"https:\/\/doi.org\/10.3390\/metabo13010129","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]}}}